Cypress Advisory Group LLC West Pharmaceutical Services Inc Transaction History
Cypress Advisory Group LLC
- $110 Billion
- Q1 2025
A detailed history of Cypress Advisory Group LLC transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Cypress Advisory Group LLC holds 3,485 shares of WST stock, worth $736,345. This represents 0.71% of its overall portfolio holdings.
Number of Shares
3,485Holding current value
$736,345% of portfolio
0.71%Shares
1 transactions
Others Institutions Holding WST
# of Institutions
815Shares Held
66.5MCall Options Held
244KPut Options Held
424K-
Vanguard Group Inc Valley Forge, PA8.99MShares$1.9 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY7.58MShares$1.6 Billion0.06% of portfolio
-
Brown Advisory Inc3.27MShares$691 Million1.1% of portfolio
-
State Street Corp Boston, MA3.25MShares$686 Million0.04% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.11MShares$657 Million1.63% of portfolio
About WEST PHARMACEUTICAL SERVICES INC
- Ticker WST
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,033,000
- Market Cap $15.6B
- Description
- West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...